CTNM Earnings Contineum Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–9 of 9
| Q1 2026 | 2026-03-31 | -0.39 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -2.17 | 2026-03-05 | 10-K |
| Q1 2026 | 2025-03-31 | -0.62 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -2.18 | 2026-03-05 | 10-K |
| Q3 2024 | 2024-09-30 | -1.61 | 2024-11-06 | 10-Q |
| Q2 2024 | 2024-06-30 | -1.35 | 2024-08-14 | 10-Q |
| FY 2024 | 2023-12-31 | 0.08 | 2025-03-06 | 10-K |
| Q3 2024 | 2023-09-30 | 0.43 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.74 | 2024-08-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.